(Created page with "{{Grenoble-Alpes}} <html lang="en"> <head> <meta name="viewport" content="width=device-width, initial-scale=1"> <LINK rel="stylesheet" type="text/css" href="http://2018.igem....") |
|||
Line 25: | Line 25: | ||
font-weight:1000px; | font-weight:1000px; | ||
margin-left:30%; | margin-left:30%; | ||
− | margin-top: | + | margin-top:30vh; |
padding-right: 20px; | padding-right: 20px; | ||
border-right: white solid 4px;} | border-right: white solid 4px;} |
Revision as of 23:09, 4 October 2018
Template loop detected: Template:Grenoble-Alpes
PROJECT
![](https://static.igem.org/mediawiki/2018/0/04/T--Grenoble-Alpes--projet_schema.png)
Project Abstract
Bacteriophages are viruses that kill specifically - and with a relative efficiency - strains from a bacterial species. They are thus a viable alternative to antibiotics that our fully automated device aims to promote.
Our project is designed to: identify a pathogenic bacterium; detect if this bacterium presents an antibiotic resistance marker; select the most effective phages for a therapy. As a proof of concept, we targeted Pseudomonas aeruginosa, a bacteria causing opportunistic lung infections in immunosuppressed patient.
We created DNA probes targeting a housekeeping gene and an antibiotic marker of PAO1. In parallel, we automated the different processes required for detection with DNA probes: from the DNA extraction after lysis to a fluorescence measurement via a bacterial transformation.
Hence, untrained healthcare professionals will eventually be able to take a sample from a patient, run it through our system, wait for a few hours and get information to decide of a therapy.